Neuren Pharmaceuticals | NEU - Ordinary Share Capital

Stock Price
11.48
Daily Change
0.08 0.70%
Monthly
-12.23%
Yearly
-6.36%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD126.64M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 2K 0 Mar/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Clinuvel Pharmaceuticals AUD 168.8M 754.23K Jun/2024
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Genetic Signatures AUD 127.64M 8.22M Dec/2024
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Medical Developments International AUD 112.66M 2.35M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Organon & Co USD 259.98M 18K Sep/2025
Paradigm Biopharmaceuticals AUD 389.43M 136.19M Jun/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025